Hayakawa Satoshi, Komine-Aizawa Shihoko, Mor Gil G
Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Department of Obstetrics and Gynecology, C.S. Mott Center for Human Growth and Development, Wayne State University, Detroit, Michigan, USA.
J Obstet Gynaecol Res. 2020 Oct;46(10):1958-1966. doi: 10.1111/jog.14384. Epub 2020 Aug 10.
At the end of 2019, a new coronavirus disease, COVID-19, emerged and quickly spread around the world. Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2), the causative virus of this disease, belongs to the β-coronavirus family, together with SARS and middle east respiratory syndrome, and has similar biological characteristics to these viruses. For obstetricians, the susceptibility and prognoses of pregnant women and the effects of the infection on the fetus have been the focus of attention; however, at present, the seriousness of the disease in pregnant women is not apparent, and COVID-19 does not increase the rate of miscarriage, stillbirth, preterm labor or teratogenicity. Even so, carriers might transmit SARS-CoV-2 to pregnant women. Thus, we must keep in mind that all medical personnel must understand and maintain standard precautions in their clinical and laboratory practices.
2019年底，一种新型冠状病毒疾病——COVID-19出现并迅速在全球传播。严重急性呼吸综合征冠状病毒2（SARS-CoV-2）是该疾病的致病病毒，与SARS和中东呼吸综合征同属β冠状病毒科，且与这些病毒具有相似的生物学特性。对于产科医生而言，孕妇的易感性和预后以及感染对胎儿的影响一直是关注焦点；然而，目前该疾病在孕妇中的严重性尚不明显，且COVID-19不会增加流产、死产、早产或致畸率。即便如此，携带者仍可能将SARS-CoV-2传播给孕妇。因此，我们必须牢记，所有医务人员在临床和实验室操作中都必须理解并遵守标准预防措施。
